Dr Neil E Fuehrer, MD - Medicare Pathology in Lincoln, NE

Dr Neil E Fuehrer, MD is a medicare enrolled "Pathology - Anatomic Pathology & Clinical Pathology" physician in Lincoln, Nebraska. He went to University Of Nebraska College Of Medicine and graduated in 2006 and has 18 years of diverse experience with area of expertise as Pathology. He is a member of the group practice North Platte Nebraska Hospital Corporation, Pathology Medical Services Pc and his current practice location is 5440 South St Ste 200, Lincoln, Nebraska. You can reach out to his office (for appointments etc.) via phone at (402) 465-1900.

Dr Neil E Fuehrer is licensed to practice in Nebraska (license number 31203) and he also participates in the medicare program. He accepts medicare assignments (which means he accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and his NPI Number is 1487835757.

Contact Information

Dr Neil E Fuehrer, MD
5440 South St Ste 200,
Lincoln, NE 68506-2116
(402) 465-1900
(402) 465-1973



Physician's Profile

Full NameDr Neil E Fuehrer
GenderMale
SpecialityPathology
Experience18 Years
Location5440 South St Ste 200, Lincoln, Nebraska
Accepts Medicare AssignmentsYes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.
  Medical Education and Training:
  • Dr Neil E Fuehrer attended and graduated from University Of Nebraska College Of Medicine in 2006
  NPI Data:
  • NPI Number: 1487835757
  • Provider Enumeration Date: 11/15/2007
  • Last Update Date: 01/17/2023
  Medicare PECOS Information:
  • PECOS PAC ID: 0446381842
  • Enrollment ID: I20211115002140

Medical Identifiers

Medical identifiers for Dr Neil E Fuehrer such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1487835757NPI-NPPES
ENROLLEDMedicaidMN

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
207ZP0102XPathology - Anatomic Pathology & Clinical Pathology 11115 (South Dakota)Secondary
207ZP0102XPathology - Anatomic Pathology & Clinical Pathology 31203 (Nebraska)Primary

Medical Facilities Affiliation

Facility NameLocationFacility Type
Bryan Medical CenterLincoln, NEHospital
Faith Regional Health ServicesNorfolk, NEHospital
Chi Health St. ElizabethLincoln, NEHospital
The Nebraska Medical CenterOmaha, NEHospital
Columbus Community HospitalColumbus, NEHospital

Group Practice Association

Group Practice NameGroup PECOS PAC IDNo. of Members
North Platte Nebraska Hospital Corporation6507856697181
Pathology Medical Services Pc064825526510

News Archive

The abuse and child delinquency link

Studies show that abused or neglected children are more likely to be arrested for delinquency and violent crimes, both as juveniles and as adults.

Genial bone advancement trephine effective treatiment for sleep apnea

Sleep disorder and ear, nose and throat specialists at Thomas Jefferson University are examining an innovative procedure to treat obstructive sleep apnea syndrome.

Actoplus Met and Actos: Mylan enters into settlement agreements with Takeda Pharmaceutical

Mylan Inc. today announced that it has entered into settlement agreements with Takeda Pharmaceutical Co. related to two treatments for type 2 diabetes: Actoplus Met®, 15 mg/500 mg and 15 mg/850 mg, known generically as Pioglitazone Hydrochloride (HCl) and Metformin HCl Tablets, and Actos®, 15 mg, 30 mg and 45 mg, known generically as Pioglitazone HCl Tablets.

Shire Canada receives expanded indication for MEZAVANT for treatment of ulcerative colitis

Shire Canada Inc., a division of Shire plc, the global specialty biopharmaceutical company, is proud to announce that MEZAVANT® (mesalamine delayed and extended release tablets), the first and only once-daily mesalamine indicated for the induction of clinical and endoscopic remission in patients with mild-to-moderate, active ulcerative colitis (UC), has received an expanded indication to include maintenance of clinical and endoscopic remission (mucosal healing) in patients with ulcerative colitis.

Blacks often diagnosed with advanced cancer, more likely to have other underlying health problems

Black people with cancer are up to twice as likely as other races to die from their disease. While disparities exist for nearly every common cancer type, the largest differences occur among cancers that benefit most from treatment - suggesting that black patients are not getting needed lifesaving treatments, according to a review from researchers at the University of Michigan Comprehensive Cancer Center.

Read more Medical News

› Verified 5 days ago

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Dr Neil E Fuehrer allows following entities to bill medicare on his behalf.
Entity NameNorth Platte Nebraska Hospital Corporation
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1700855533
PECOS PAC ID: 6507856697
Enrollment ID: O20040512000889

News Archive

The abuse and child delinquency link

Studies show that abused or neglected children are more likely to be arrested for delinquency and violent crimes, both as juveniles and as adults.

Genial bone advancement trephine effective treatiment for sleep apnea

Sleep disorder and ear, nose and throat specialists at Thomas Jefferson University are examining an innovative procedure to treat obstructive sleep apnea syndrome.

Actoplus Met and Actos: Mylan enters into settlement agreements with Takeda Pharmaceutical

Mylan Inc. today announced that it has entered into settlement agreements with Takeda Pharmaceutical Co. related to two treatments for type 2 diabetes: Actoplus Met®, 15 mg/500 mg and 15 mg/850 mg, known generically as Pioglitazone Hydrochloride (HCl) and Metformin HCl Tablets, and Actos®, 15 mg, 30 mg and 45 mg, known generically as Pioglitazone HCl Tablets.

Shire Canada receives expanded indication for MEZAVANT for treatment of ulcerative colitis

Shire Canada Inc., a division of Shire plc, the global specialty biopharmaceutical company, is proud to announce that MEZAVANT® (mesalamine delayed and extended release tablets), the first and only once-daily mesalamine indicated for the induction of clinical and endoscopic remission in patients with mild-to-moderate, active ulcerative colitis (UC), has received an expanded indication to include maintenance of clinical and endoscopic remission (mucosal healing) in patients with ulcerative colitis.

Blacks often diagnosed with advanced cancer, more likely to have other underlying health problems

Black people with cancer are up to twice as likely as other races to die from their disease. While disparities exist for nearly every common cancer type, the largest differences occur among cancers that benefit most from treatment - suggesting that black patients are not getting needed lifesaving treatments, according to a review from researchers at the University of Michigan Comprehensive Cancer Center.

Read more Medical News

› Verified 5 days ago

Entity NamePathology Medical Services Pc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1851455646
PECOS PAC ID: 0648255265
Enrollment ID: O20041022000417

News Archive

The abuse and child delinquency link

Studies show that abused or neglected children are more likely to be arrested for delinquency and violent crimes, both as juveniles and as adults.

Genial bone advancement trephine effective treatiment for sleep apnea

Sleep disorder and ear, nose and throat specialists at Thomas Jefferson University are examining an innovative procedure to treat obstructive sleep apnea syndrome.

Actoplus Met and Actos: Mylan enters into settlement agreements with Takeda Pharmaceutical

Mylan Inc. today announced that it has entered into settlement agreements with Takeda Pharmaceutical Co. related to two treatments for type 2 diabetes: Actoplus Met®, 15 mg/500 mg and 15 mg/850 mg, known generically as Pioglitazone Hydrochloride (HCl) and Metformin HCl Tablets, and Actos®, 15 mg, 30 mg and 45 mg, known generically as Pioglitazone HCl Tablets.

Shire Canada receives expanded indication for MEZAVANT for treatment of ulcerative colitis

Shire Canada Inc., a division of Shire plc, the global specialty biopharmaceutical company, is proud to announce that MEZAVANT® (mesalamine delayed and extended release tablets), the first and only once-daily mesalamine indicated for the induction of clinical and endoscopic remission in patients with mild-to-moderate, active ulcerative colitis (UC), has received an expanded indication to include maintenance of clinical and endoscopic remission (mucosal healing) in patients with ulcerative colitis.

Blacks often diagnosed with advanced cancer, more likely to have other underlying health problems

Black people with cancer are up to twice as likely as other races to die from their disease. While disparities exist for nearly every common cancer type, the largest differences occur among cancers that benefit most from treatment - suggesting that black patients are not getting needed lifesaving treatments, according to a review from researchers at the University of Michigan Comprehensive Cancer Center.

Read more Medical News

› Verified 5 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr Neil E Fuehrer is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Dr Neil E Fuehrer, MD
5440 South St Ste 200,
Lincoln, NE 68506-2116

Ph: (402) 465-1900
Dr Neil E Fuehrer, MD
5440 South St Ste 200,
Lincoln, NE 68506-2116

Ph: (402) 465-1900

News Archive

The abuse and child delinquency link

Studies show that abused or neglected children are more likely to be arrested for delinquency and violent crimes, both as juveniles and as adults.

Genial bone advancement trephine effective treatiment for sleep apnea

Sleep disorder and ear, nose and throat specialists at Thomas Jefferson University are examining an innovative procedure to treat obstructive sleep apnea syndrome.

Actoplus Met and Actos: Mylan enters into settlement agreements with Takeda Pharmaceutical

Mylan Inc. today announced that it has entered into settlement agreements with Takeda Pharmaceutical Co. related to two treatments for type 2 diabetes: Actoplus Met®, 15 mg/500 mg and 15 mg/850 mg, known generically as Pioglitazone Hydrochloride (HCl) and Metformin HCl Tablets, and Actos®, 15 mg, 30 mg and 45 mg, known generically as Pioglitazone HCl Tablets.

Shire Canada receives expanded indication for MEZAVANT for treatment of ulcerative colitis

Shire Canada Inc., a division of Shire plc, the global specialty biopharmaceutical company, is proud to announce that MEZAVANT® (mesalamine delayed and extended release tablets), the first and only once-daily mesalamine indicated for the induction of clinical and endoscopic remission in patients with mild-to-moderate, active ulcerative colitis (UC), has received an expanded indication to include maintenance of clinical and endoscopic remission (mucosal healing) in patients with ulcerative colitis.

Blacks often diagnosed with advanced cancer, more likely to have other underlying health problems

Black people with cancer are up to twice as likely as other races to die from their disease. While disparities exist for nearly every common cancer type, the largest differences occur among cancers that benefit most from treatment - suggesting that black patients are not getting needed lifesaving treatments, according to a review from researchers at the University of Michigan Comprehensive Cancer Center.

Read more News

› Verified 5 days ago


Pathology Doctors in Lincoln, NE

Dr. Aina Inese Silenieks, MD
Pathology
Medicare: Not Enrolled in Medicare
Practice Location: 5440 South Street, Suite 200, Lincoln, NE 68506
Phone: 402-465-1900    Fax: 402-465-1940
Dr. Tyler Ryan Teichmeier, M.D.
Pathology
Medicare: Accepting Medicare Assignments
Practice Location: 5440 South St Ste 200, Lincoln, NE 68506
Phone: 402-465-1900    
Matthias I Okoye, M.D.
Pathology
Medicare: Not Enrolled in Medicare
Practice Location: 600 S 70th St, Lincoln, NE 68510
Phone: 402-486-3447    Fax: 402-486-3477
Dr. Deborah Kay Davidson, DO
Pathology
Medicare: Not Enrolled in Medicare
Practice Location: 5440 South Street, Suite 200, Lincoln, NE 68506
Phone: 402-465-1900    Fax: 402-465-1940
Jon R Steinhauer, MD
Pathology
Medicare: Accepting Medicare Assignments
Practice Location: 5440 South St Ste 200, Lincoln, NE 68506
Phone: 402-465-1900    Fax: 402-465-1940
Dr. Charles Meehan Reese, MD
Pathology
Medicare: Accepting Medicare Assignments
Practice Location: 5440 South Street, Suite 200, Lincoln, NE 68506
Phone: 402-465-1900    Fax: 402-465-1940

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.